GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

XORTX Therapeutics XRTX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.84

-5.73%

Close of 20 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

XORTX Therapeutics — daily XRTX Delayed
Market value
$1.5m
Last close × shares
Volume
47.9k
Shares, 20 Nov 2026

About XORTX Therapeutics

Its shares trade under the ticker XRTX. It has been listed since 28 November 2018.

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the treatment of autosomal dominant polycystic kidney disease; XRx-101, which is in Phase II for the treatment of acute kidney injury associated with respiratory virus infection, including sepsis and coronavirus; and XRX-225, which is in preclinical stage for the treatment of type 2 diabetic nephropathy, as well as VB4-P5, a program for the treatment and prevention of fibrosis in the kidney. The company is based in Calgary, Canada.

Figures and description from our data supplier, not checked against the company's own report.

More about XORTX Therapeutics →

Latest on XORTX Therapeutics

Our reporting

Next results

1 Apr 2027

Due on 1 Apr 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is XORTX Therapeutics's ticker?

XORTX Therapeutics trades as XRTX on its US listing, under ISIN CA98420Q2071.

What was XORTX Therapeutics's last closing price?

0.84 on 20 Nov 2026. The figure is in USD and is never converted.

When does XORTX Therapeutics next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.